- Home
- FOXF vs RCKT Comparison
FOXF vs RCKT Comparison
Compare FOXF & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FOXF | RCKT |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.2M | 428.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FOXF | RCKT |
|---|---|---|
| Price | $19.10 | $3.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | ★ $30.67 | $29.12 |
| AVG Volume (30 Days) | 554.5K | ★ 2.2M |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,459,086,000.00 | N/A |
| Revenue This Year | $6.82 | N/A |
| Revenue Next Year | $3.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.22 | N/A |
| 52 Week Low | $13.08 | $2.19 |
| 52 Week High | $31.18 | $11.45 |
Technical Indicators
Market Signals| Indicator | FOXF | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 61.75 | 54.05 |
| Support Level | $18.90 | $3.43 |
| Resistance Level | $19.94 | $3.96 |
| Average True Range (ATR) | 0.71 | 0.24 |
| MACD | 0.06 | -0.01 |
| Stochastic Oscillator | 71.53 | 46.77 |
Price Performance
Historical ComparisonAbout FOXF Fox Factory Holding Corp.
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.